The clinical literature on aloe and burns is real but thin. A 2007
systematic review by Maenthaisong and colleagues identified four controlled
trials (n=371) of aloe preparations for first- and second-degree burns and
pooled a healing-time advantage of roughly nine days over comparator
dressings — while stating plainly that the included studies were few, small
and methodologically weak [5].
The individual trials behind that pooling are instructive. Visuthikosol and
colleagues (1995) compared aloe gel with vaseline gauze in 27 patients with
partial-thickness burns and reported healing at 11.9 versus 18.2 days, with
supporting histology [6]. Khorasani and colleagues (2009) ran a
within-patient comparison of an aloe cream against silver sulfadiazine on
paired burn sites in 30 patients and reported re-epithelialisation at 15.9
versus 18.7 days [7]. Both are small, unblinded, single-centre studies, and
the preparations differ — fresh gel, cream, gel-impregnated gauze — so the
results cannot be attributed to any standardised product.
That is the shape of a grade B: human trials exist, they point in a
consistent direction for minor superficial burns, and none of them is
large, blinded or standardised enough to settle the question.
A second systematic review has since been published, this time from
Universiti Kebangsaan Malaysia: eleven controlled clinical trials from
2015 to 2022 of aloe gel and cream in pressure injuries, chronic ulcers
and diabetic foot ulcers [10]. A Malaysian-authored mechanistic review
addresses which constituents drive the proliferative phase of repair [11].
The direction of the literature has not changed — the trials remain small
and the preparations remain unstandardised — but the systematic-review
rung is now well established for this botanical.